iinews – Der mobile Newsdienst



« | »

Tumor Profiling Market Analysis, Regions and Application, Growth, Key Manufacturers Forecast To 2022

 

The report \“Cancer/Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) – Global Forecast to 2022\“, is projected to reach USD 8.74 Billion by 2022 from USD 5.26 Billion in 2017, at a CAGR of 10.7%.
Major factors fueling the growth of the market include increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research. On the other hand, high capital investments and low benefit ratio for biomarkers used in cancer/tumor profiling are expected to limit the cancer/tumor profiling market growth to a certain extent. Factors such as the increasing demand for personalized medicine and point-of-care diagnostic tests in cancer/tumor profiling are expected to offer a wide range of growth opportunities for players in the cancer/tumor profiling market.

Download PDF Sample Pages of Tumor Profiling Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1250

Scope of the Report

This research report categorizes the global market on the basis of technology, cancer type, application, and region

Global Tumor Profiling Market, by Application
• Clinical Applications
• Research Applications
Global Tumor Profiling Market, by Technology
• Immunoassays
• Hybridization
• Next-generation Sequencing
• Mass Spectroscopy
• Other Technologies (Pyrosequencing and Sanger Sequencing)
Global Tumor Profiling Market, by Cancer Type
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Melanoma Cancer
• Other Cancer Types (Non-Hodgkin’s Lymphoma, Melanoma, Leukemia, Thyroid, Bladder, and Kidney)
Global Tumor Profiling Market, by Region
• North America
o US
o Canada
• Europe
• Asia Pacific
• Rest of the World (RoW)

Speak with our Experts @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1250

Major players operating in the cancer profiling market include
Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the tumor profiling market.

Other major players in the market include Caris Life Sciences. (U.S.), Helomics Corporation (U.S.), and NanoString Technologies, Inc. (U.S.).

Objectives of the Study
• To define, describe, and forecast the tumor profiling market on the basis of application, technology, cancer type, and region
• To provide a detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market
• To analyze the opportunities in the market for stakeholders and details of a competitive landscape for market leaders
• To forecasting the revenue of market segments with respect to four main geographies (along with countries), namely, North America, Europe, Asia Pacific, and the RoW
• To profile key players and comprehensively analyze their market shares and core competencies
• To track and analyze competitive developments such as collaborations, new product developments, product enhancements, and R&D activities in the tumor profiling market

Get Sample Report with all Graphs & Charts related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1250

Posted by on 24. April 2019.

Tags: , , , , , , , ,

Categories: Bilder, Vermischtes

0 Responses

You must be logged in to post a comment.

« | »




Neue Beiträge


Seiten